Desfechos e fatores prognósticos no carcinoma lobular invasivo triplo-negativo (TN) e ctDNA na doença luminal e TN 

Notas do episódio

Referências: Joshi, U., Budhathoki, P., Gaire, S. et al. Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast. Breast Cancer Res Treat 200, 217–224 (2023). https://doi.org/10.1007/s10549-023-06959-3 ou https://link.springer.com/article/10.1007/s10549-023-06959-3 Magbanua MJM, Brown Swigart L, Ahmed Z, Sayaman RW, Renner D, Kalashnikova E, Hirst GL, Yau C, Wolf DM, Li W, Delson AL, Asare S, Liu MC, Albain K, Chien AJ, Forero-Torres A, Isaacs C, Nanda R, Tripathy D, Rodriguez A, Sethi H, Aleshin A, Rabinowitz M, Perlmutter J, Symmans WF, Yee D, Hylton NM, Esserman LJ, DeMichele AM, Rugo HS, van 't Veer LJ. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy. Cancer Cell. 2023 Jun 12;41(6):1091-1102.e4. doi: 10.1016/j.ccell.2023.04.008. Epub 2023 May 4. PMID: 37146605. https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00134-4